XSES
A50
Market cap1.10bUSD
Sep 17, Last price
0.05SGD
1D
-1.85%
1Q
-1.85%
Jan 2017
-48.04%
IPO
-75.46%
Name
Thomson Medical Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
Key people
Ser Miang Ng
Non-Executive Independent Chairman of the Board · since 2015
Zing Yuen Tan
Group Finance Director, Chief Risk Officer · since 2019
Hin Kay Hong
Chairman, RSP Architects Planners & Engineers (Pte) Ltd · since 2013
Swee Chiew Beh
Managing Director - RSP · since 2017
Yann Teo
Managing Director - Squire Mech · since 2017
Wee Tuck Tan
Chief Executive Officer, Executive Director · since 2018
Chiang Yin Wong
Executive Director and Group Chief Executive Officer · since 2020
Kut Cheung Lee
Senior Director - RSP · since 2017
Thai Ker Liu
Senior Director of RSP Architects Planners & Engineers (Pte) Ltd · since 2013
Eng Kiong Ng
Senior Director - Squire Mech · since 2017
Kai Hoo Quek
Head - Investments · since 2013
Lan Fong Tan
Head - Human Resources
Hasan Malik bin Abdul Quddoos
Head - Legal & Secretariat and Joint Company Secretary · since 2017
Soon Soo Foo
Joint Company Secretary · since 2018
Pin Kwan Lee
Joint Company Secretary · since 2017
Hoi Leong Lim
Joint Company Secretary · since 2018
Wee Kiat Lim
Non-Executive and Non-Independent Director · since 2019
Non-Executive Independent Director · since 2016
Legal address
101 Thomson Road
#20-04/05
United Square
Singapore, 01 307591
SG
#20-04/05
United Square
Singapore, 01 307591
SG
Headquarters
101 Thomson Road
#20-04/05
United Square
Singapore 307591
SG
#20-04/05
United Square
Singapore 307591
SG
Previous name
ROWSLEY LTD.
Previous name
ASPNETCENTRE LTD
Previous name
ASP HOLDINGS PTE LTD
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||